A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia.

Abstract

Schizophrenia is a neuropsychiatric disorder characterized by various symptoms including autonomic imbalance. These disturbances involve almost all autonomic functions and might contribute to poor medication compliance, worsened quality of life and increased mortality. Therefore, it has a great importance to find a potential therapeutic solution to improve the autonomic disturbances. The altered level of kynurenines (e.g., kynurenic acid), as tryptophan metabolites, is almost the most consistently found biochemical abnormality in schizophrenia. Kynurenic acid influences different types of receptors, most of them involved in the pathophysiology of schizophrenia. Only few data suggest that kynurenines might have effects on multiple autonomic functions. Publications so far have discussed the implication of kynurenines and the alteration of the autonomic nervous system in schizophrenia independently from each other. Thus, the coupling between them has not yet been addressed in schizophrenia, although their direct common points, potential interfaces indicate the consideration of their interaction. The present review gathers autonomic disturbances, the impaired kynurenine pathway in schizophrenia, and the effects of kynurenine pathway on autonomic functions. In the last part of the review, the potential interaction between the two systems in schizophrenia, and the possible therapeutic options are discussed.

• Authors: Alexandra Büki, Gabriella Kekesi, Gyongyi Horvath, László Vécsei
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 22 Issue 18 (Sep 16 2021) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 34576179 (Publication Type: Journal Article, Review)

Chemical References

• Kynurenine
• Kynurenic Acid

Topics

• Animals
• Autonomic Nervous System (metabolism)
• Humans
• Kynurenic Acid (metabolism)
• Kynurenine (metabolism)
• Schizophrenia (metabolism)